News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
August, 2025
August 2025
M T W T F S S
 123
45678910
11121314151617
18192021222324
25262728293031
Just presented at ASCO24: IMROZ results by C. Ola Landgren – ASCO
Photo taken from ASCO/X
Jun 4, 2024, 16:31

Just presented at ASCO24: IMROZ results by C. Ola Landgren – ASCO

ASCO shared a post on X:

“Just presented at American Society of Clinical Oncology 2024 (ASCO24), IMROZ results- lsatuximab, bortezomib, lenalidomide, and dexamethasone (Isa-VRd) significantly improved Progression-Free Survival (PFS) in patients with transplant-ineligible, newly diagnosed Multiple Myeloma versus Velcade, Revlimid and dexamethasone (VRd) with no new safety concerns.”

Additional information
Source: ASCO/X

ASCO ASCO24 C. Ola Landgren cancer dexamethasone IMROZ Isatuximab multiple myeloma OncoDaily Oncology progression-free survival Revlimid Velcade
Special Coverage
Insight
Aug 2, 2025, 00:36
Elizabeth Smyth: Review on a Key Emerging Biomarker in Gastric and Gastroesophageal Cancer
Blog
Aug 2, 2025, 00:00
Maryam Lustberg: Discussing PCPs vs Oncologists
Insight
Aug 1, 2025, 19:58
Anirban Maitra: In Vivo Screening Reveals Cell-Intrinsic Mediators of Solid Tumor Resistance to CAR T Cell-Therapy
Blog
Aug 1, 2025, 19:24
Oliver Bogler: What Reviewers Hate to See
Blog
Aug 1, 2025, 19:14
The Impact Your Support Makes in the Fight Against Cancer - NFCR
Blog
Aug 1, 2025, 19:10
YARN: An Ambitious, Bold and Promising EU-Funded Initiative - Youth Cancer Europe
Science
Aug 1, 2025, 19:04
Karen Knudsen: Science in Action - Men with Advanced Prostate Cancer Benefit
Positive
Aug 1, 2025, 18:57
Two Behaviour Change Campaigns Are the Finalists at 2025 Effie Awards - Cancer Institute NSW
Blog
Aug 1, 2025, 18:53
Marty Makary: Looking Forward to FDA National Listening Tour with Pharmaceutical and Biotech CEOs
Career
Aug 1, 2025, 18:52
Brian A. Walker Joins Sylvester Myeloma Institute - Sylvester Comprehensive Cancer Center
Blog
Aug 1, 2025, 18:42
Identifying and Preparing Eligible Patients for Screening with Confidence - ACS NLCRT
Insight
Aug 1, 2025, 18:37
Miguel Bronchud: SEOM Has Published the 2025 Medical Oncology Research Dossier in English